Importation of US-labelled Dexamethasone Sodium Phosphate Injection, USP 4 mg/mL due to the Current Shortage of Canadian-authorized Dexamethasone Sodium Phosphate Injection, USP 4 mg/mL

Healthcare professionals are advised to refer to the Canadian Prescribing Information for Dexamethasone Sodium Phosphate Injection USP, 4 mg/mL by Sandoz Canada Inc. (DIN 00664227) available in English and French on the Health Canada Drug Product Database (Product information) for proper use of the imported product, including information for the indications, contraindications, warnings and precautions, adverse reactions, dosage, administration, and storage.